Enhanced resection and improved survival in murine neuroblastoma (C1300-NB) after preoperative immunotherapy. 1991

C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
Department of Surgery, School of Medicine and Biomedical Sciences, State University of New York, Buffalo.

Advanced neuroblastoma treated with standard chemotherapy has a poor prognosis. Combination immunotherapy for murine neuroblastoma with retinyl palmitate, low-dose cyclophosphamide, and interleukin-2 resulted in increased survival, impaired tumor growth, easier surgical resection, and increased class I expression or tumor cells. Preoperative immunotherapy may be useful in treatment of advanced human neuroblastoma.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D005260 Female Females

Related Publications

C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
July 1994, Annals of surgical oncology,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
January 1995, Peptides,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
December 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
January 1976, Oncology,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
December 1995, Journal of pediatric surgery,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
January 1975, Cancer chemotherapy reports,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
May 1980, Biochimica et biophysica acta,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
January 1988, Current surgery,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
March 1975, European journal of cancer,
C L Fowler, and S P Brooks, and R Squire, and G A Rich, and J E Rossman, and M J Finegold, and J E Allen, and D R Cooney
January 1993, Cancer biotherapy,
Copied contents to your clipboard!